Response

Abstract

Dear Editor,We wholeheartedly agree with Tendas et al. that education on chemotherapy-induced nausea and vomiting (CINV) in bone marrow transplant (BMT) patients is important and might improve outcomes [1][2][3][4].While we did not ask our survey participants if they took care of BMT patients, one could speculate that the 15-22 % who indicated they disagreed with the need for education on this topic were likely not involved with BMT patients [1]. Importantly, in our survey, a full 78 to 85 % of hematology/ oncology physicians and nurses, respectively, indicated they either agreed or strongly agreed that education on the prevention/management of CINV in BMT is warranted.That CINV occurs in patients undergoing BMT is reason enough to offer further education on this topic to health-care providers. We applaud the efforts of Tendas and colleagues to raise awareness of this unmet need and agree that a survey to better understand the specific education needs of clinicians who manage CINV in the BMT setting would be beneficial. References